Multivariate and univariate analysis of prognostic factors following resection in HCC: The Birmingham experience

被引:20
作者
John, Abraham R. [1 ]
Khan, Saboor [1 ]
mirza, Darius F. [1 ]
Mayer, A. David [1 ]
Buckels, John A. C. [1 ]
Bramhall, Simon R. [1 ]
机构
[1] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England
关键词
hepatocellular carcinoma; cirrhosis; alpha-fetoprotein; hepatectomy;
D O I
10.1159/000093779
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. The aim of this study was to look into our experience of resection for hepatocellular carcinomas (HCCs) in a tertiary Hepatobiliary and Liver Transplant Unit in the UK. Methods: A retrospective analysis of our prospective database was carried out. Results: 715 cases of HCC were seen. 100 (13.9%) underwent hepatic resection and 159 (22.2%) orthotopic liver transplant. The 1-, 3- and 5-year overall survival following resection was 75.3, 37.0 and 21.5% respectively. Factors affecting long-term survival included resection margin (p < 0.001), recurrence (p < 0.007), alpha-fetoprotein > 50 (p < 0.001) and serum albumin (p < 0.03). On multivariate analysis, recurrence (p < 0.001) and histological grade (p < 0.044) were significant. The 1- and 3-year recurrence rates were 27.3 and 72.5% respectively. Histological grade (p < 0.007), alpha-fetoprotein > 50 (p < 0.033), female gender (p < 0.016) and portal vein involvement (p < 0.016) were significant in recurrence. Conclusions: Resection data from the East may not be comparable to the West owing to the higher transplant activity in the latter. Liver function tests and imaging would be sufficient to assess liver function prior to hepatic resection. HCC with cirrhosis should be assessed by a transplant unit prior to any treatment. The MELD (Model for End-Stage Liver Disease) score would be a valuable preoperative tool in the assessment of cirrhotics. Copyright Q 2006 S. Karger AG, Basel.
引用
收藏
页码:103 / 109
页数:7
相关论文
共 39 条
[1]  
BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO
[2]  
2-J
[3]   Underlying liver disease, not tumor factors, predicts long-term survival alter resection of hepatocellular carcinoma [J].
Bilimoria, MM ;
Lauwers, GY ;
Doherty, DA ;
Nagorncy, DM ;
Belghiti, J ;
Do, KA ;
Regimbeau, JM ;
Ellis, LM ;
Curley, SA ;
Ikai, I ;
Yamaoka, Y ;
Vauthey, JN .
ARCHIVES OF SURGERY, 2001, 136 (05) :528-534
[4]   NATURAL-HISTORY OF HEPATOCELLULAR-CARCINOMA IN SPAIN - 5 YEARS EXPERIENCE IN 249 CASES [J].
CALVET, X ;
BRUIX, J ;
BRU, C ;
GINES, P ;
VILANA, R ;
SOLE, M ;
AYUSO, MD ;
BRUGUERA, M ;
RODES, J .
JOURNAL OF HEPATOLOGY, 1990, 10 (03) :311-317
[5]  
CHEN DS, 1977, CANCER, V40, P779, DOI 10.1002/1097-0142(197708)40:2<779::AID-CNCR2820400227>3.0.CO
[6]  
2-Y
[7]  
DENIS J, 1984, GASTROEN CLIN BIOL, V8, P920
[8]   HEPATITIS-C AND HEPATOCELLULAR-CARCINOMA [J].
DIBISCEGLIE, AM .
SEMINARS IN LIVER DISEASE, 1995, 15 (01) :64-69
[9]   Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients [J].
Fattovich, G ;
Giustina, G ;
Degos, F ;
Tremolada, F ;
Diodati, G ;
Almasio, P ;
Nevens, F ;
Solinas, A ;
Mura, D ;
Brouwer, JT ;
Thomas, H ;
Njapoum, C ;
Casarin, C ;
Bonetti, P ;
Fuschi, P ;
Basho, J ;
Tocco, A ;
Bhalla, A ;
Galassini, R ;
Noventa, F ;
Schalm, SW ;
Realdi, G .
GASTROENTEROLOGY, 1997, 112 (02) :463-472
[10]  
FONG ST, 1995, ARCH SURG-CHICAGO, V130, P198